As of 2024-12-12, the EV/EBITDA ratio of USANA Health Sciences Inc (USNA) is 3.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. USNA's latest enterprise value is 354.44 mil USD. USNA's TTM EBITDA according to its financial statements is 94.79 mil USD. Dividing these 2 quantities gives us the above USNA EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 10.8x | 7.2x |
| Forward P/E multiples | 8.3x - 11.9x | 10.1x |
| Fair Price | 49.88 - 82.73 | 64.06 |
| Upside | 32.2% - 119.2% | 69.8% |
| Date | EV/EBITDA |
| 2024-12-11 | 3.71 |
| 2024-12-10 | 3.89 |
| 2024-12-09 | 3.82 |
| 2024-12-06 | 3.65 |
| 2024-12-05 | 3.73 |
| 2024-12-04 | 3.91 |
| 2024-12-03 | 3.84 |
| 2024-12-02 | 4.20 |
| 2024-11-29 | 3.90 |
| 2024-11-27 | 4.02 |
| 2024-11-26 | 3.80 |
| 2024-11-25 | 4.18 |
| 2024-11-22 | 4.17 |
| 2024-11-21 | 4.07 |
| 2024-11-20 | 4.10 |
| 2024-11-19 | 4.00 |
| 2024-11-18 | 4.07 |
| 2024-11-15 | 4.26 |
| 2024-11-14 | 4.08 |
| 2024-11-13 | 4.38 |
| 2024-11-12 | 4.30 |
| 2024-11-11 | 4.45 |
| 2024-11-08 | 4.24 |
| 2024-11-07 | 4.30 |
| 2024-11-06 | 4.26 |
| 2024-11-05 | 3.99 |
| 2024-11-04 | 3.77 |
| 2024-11-01 | 3.65 |
| 2024-10-31 | 3.58 |
| 2024-10-30 | 3.54 |
| 2024-10-29 | 3.65 |
| 2024-10-28 | 3.65 |
| 2024-10-25 | 3.55 |
| 2024-10-24 | 3.75 |
| 2024-10-23 | 3.51 |
| 2024-10-22 | 3.08 |
| 2024-10-21 | 3.20 |
| 2024-10-18 | 3.36 |
| 2024-10-17 | 3.44 |
| 2024-10-16 | 3.53 |
| 2024-10-15 | 3.44 |
| 2024-10-14 | 3.31 |
| 2024-10-11 | 3.35 |
| 2024-10-10 | 3.35 |
| 2024-10-09 | 3.27 |
| 2024-10-08 | 3.40 |
| 2024-10-07 | 3.28 |
| 2024-10-04 | 3.38 |
| 2024-10-03 | 3.27 |
| 2024-10-02 | 3.47 |